Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
faq Vaginal Laxity (postnatalmenopause support)

Should I try pelvic physio before laser/RF or injectables?

Should I try pelvic physio before laser/RF or injectables? Yes—supervised pelvic floor muscle training (PFMT) is the recommended first step for perceived vaginal laxity and related symptoms, with moisturisers/lubricants and (if acceptable) local vaginal oestrogen for GSM. Physio builds activation, endurance and timing (“the knack”), often resolving air-trapping, micro-tears and early-penetration discomfort without procedures. Devices or injectables are optional adjuncts only if targeted gaps remain after a strong physio block. Educational only. Results vary. Not a cure.

Clinical Context

Who benefits most from physio-first? Postnatal or peri-/post-menopausal women with mild, entry-focused issues—air-trapping, early-penetration discomfort, “loose yet sore” with GSM—without prolapse beyond the introitus or a clearly malpositioned scar. PFMT plus GSM care often meets goals without procedures.

Who needs earlier specialist review? Women with suspected perineal scar malposition altering the introitus, a defined fascial defect/rectocele, or new post-menopausal bleeding, malodorous discharge, fever, or deep pelvic pain. These require diagnostic clarity; devices/injectables won’t correct structure or treat red flags.

Next steps now. Start/continue a supervised 12-week PFMT block; schedule a moisturiser 2–4 nights weekly; use a generous compatible lubricant (water-based for versatility/condoms; silicone-based for longest glide; avoid oil with latex). Reassess at 6–12 weeks. Proceed to an adjunct only if a specific gap remains and goals are realistic.

Evidence-Based Approaches

NHS (patient-friendly): Step-by-step guidance for pelvic floor exercises and self-care for vaginal dryness (GSM) anchors first-line management.

NICE guideline NG123: Recommends supervised pelvic floor muscle training as first-line for urinary incontinence/prolapse and sets criteria for escalation—principles that underpin a physio-first pathway for laxity-type concerns. NICE NG123.

RCOG patient information: Clear explanations of pelvic floor dysfunction and postnatal recovery reinforce conservative care before procedures. RCOG – pelvic floor dysfunction.

Cochrane reviews: Method-rigorous overviews show pelvic floor muscle training improves symptoms and quality of life, supporting PFMT as a cornerstone before considering devices/injectables. Cochrane Library – PFMT reviews.

Peer-reviewed GSM context: Public abstracts summarise how oestrogen decline alters mucosa and pH—explaining why moisturisers, lubricants and local oestrogen improve comfort and perceived support. PubMed – GSM overview.